XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Restatement of Previously Issued Unaudited Condensed Financial Statements - Statements of Cash Flows (Details) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (33,990,919) $ (17,602,400)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 3,746,022 7,694,716
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 3,776,212 (4,815,873)
Accounts payable (2,034,857) 1,157,631
Accrued expenses (2,098,786) (137,610)
Net cash used in operating activities (30,602,328) (13,703,536)
Cash flows from financing activities:    
Proceeds from exercise of stock options 8,386 4,613
Net cash provided by financing activities 8,579,577 4,613
Net (decrease) increase in cash and cash equivalents (22,022,751) (13,698,923)
Cash and cash equivalents, beginning of year 28,377,693 45,686,014
Cash and cash equivalents, end of period $ 6,354,942 31,987,091
As Reported    
Cash flows from operating activities:    
Net loss   (22,233,790)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense   7,694,716
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets   (184,483)
Accounts payable   1,157,631
Accrued expenses   (137,610)
Net cash used in operating activities   (13,703,536)
Cash flows from financing activities:    
Proceeds from exercise of stock options   4,613
Net cash provided by financing activities   4,613
Net (decrease) increase in cash and cash equivalents   (13,698,923)
Cash and cash equivalents, beginning of year   45,686,014
Cash and cash equivalents, end of period   31,987,091
Restatement Impacts    
Cash flows from operating activities:    
Net loss   4,631,390
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets   $ (4,631,390)